Wolverine
BPC-157 + TB-500
A Regenerative Approach to Recovery, Repair, and Performance
1,000 + Patients Served
24 /7 Telehealth Access
15 + Treatments Available
98 % Patient Satisfaction
Overview
The “Wolverine Protocol” refers to a combination peptide approach using BPC-157 and TB-500, designed to support the body’s natural healing and recovery processes. This protocol is utilized in regenerative and performance-focused settings to target tissue repair and recovery at a systemic level.
Potential Clinical Applications
Support for patients with chronic soft tissue discomfort
Recovery optimization following strain, overuse, or athletic activity
Adjunctive therapy for tendon, ligament, and muscle healing
Support for musculoskeletal injury recovery
Clinical Rationale
This combination is associated with biologic pathways involved in:
Cellular migration and tissue regeneration
Angiogenesis and microvascular support
Muscle, tendon, and ligament repair processes
Modulation of inflammatory signaling
These mechanisms are central to recovery from injury and restoration of functional tissue integrity.
Administration
The Wolverine Protocol is typically administered via subcutaneous injection. Dosing strategies and duration are individualized based on patient-specific goals and clinical context.
Sample Dosing Protocol (Example Only): 250 mcg administered by subcutaneous injection once daily for 4–8 weeks.
Wellness & Regenerative Focus
This therapy is part of a broader regenerative strategy aimed at enhancing recovery capacity, supporting tissue resilience, and optimizing physical performance.
This information is provided for educational purposes and reflects a general overview of studied biologic mechanisms. Statements have not been evaluated by the FDA. Individual protocols, appropriateness, and outcomes are determined on a case-by-case basis following clinical evaluation. Individual results may vary.